Hyaluronic Acid Products Market

Hyaluronic Acid Products Market (Product: Single-injection Cycle, Three-injection Cycle, and Five-injection Cycle; and Application: Osteoarthritis, Ophthalmic Surgery, Dermal Fillers, and Vesicoureteral Reflux [VUR]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Hyaluronic Acid Products Market Outlook 2028

  • The global hyaluronic acid products market was valued at US$ 8.5 Bn in 2020
  • It is estimated to expand at a CAGR of 7.1% from 2021 to 2028
  • The global hyaluronic acid products market is expected to cross the value of US$ 15.2 Bn by the end of 2028

Analysts’ Viewpoint on Hyaluronic Acid Products Market Scenario

Manufacturers in the hyaluronic acid products market are focusing on positive or limited negative-impact sectors such as orthopedic and ophthalmic end-use cases to keep the economies running during the ongoing COVID-19 pandemic. However, hyaluronic acid is associated with the possibility of redness and soreness when injected into the joint. Hence, manufacturers in the hyaluronic acid products market should increase awareness about the advantages of this compound, since this molecule only leads to rare cases of allergic reactions. With the rising prevalence of osteoarthritis, new uses of the molecule is being researched. Hyaluronic acid products are finding applications in reversing skin aging by modulating skin moisture.

Dermal Fillers Create Stable Revenue Streams for Market Stakeholders

The key revenue-generating applications of hyaluronic acid products are dermal fillers, osteoarthritis, ophthalmic surgery, and vesicoureteral reflux (VUR). Of these, the revenue of dermal fillers held the dominant share in the past few years, closely followed by the osteoarthritis and vesicoureteral reflux applications. Meanwhile, the revenue of vesicoureteral reflux is projected to rise at a promising rate over the forecast period. The spectacular pace of the growth of this application is primarily driven by the rising demand for minimally invasive surgical procedures. In addition, the burgeoning aging population in several developed and developing nations who need eye & orthopedic surgeries is further fueling the growth of the hyaluronic acid products market.

Request a sample to get extensive insights into the Hyaluronic Acid Products Market

Reopening of Country Borders Helping to Fuel Trade amid COVID-19 Pandemic

Manufacturers in the hyaluronic acid products market are conducting short-term, mid-term, and long-term planning to overcome interruptions across customer demand, supply of materials, and availability of logistics services. They are analyzing high-risk clients and customers where recovery of debt may be an issue amid the ongoing COVID-19 outbreak. The scarcity of raw materials is likely to be experienced due to production stoppages and labor shortages during the ongoing pandemic. Nevertheless, the reopening of country borders is helping resolve transport and logistic issues, owing to stringent regulations being followed during transport of raw materials for the hyaluronic acid products market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

High Prevalence of Cancer Patients and Geriatric Population Contributes to Market Growth

The number of people ageing in North America and Europe is so high that in the year 2028, the number of people aged between 65 and above is estimated to be more than the number of children aged between five & below. Since the molecule of hyaluronic acid helps in drug delivery, wound repair, skin healing, etc., the geriatric population would be an important consumer base.

Additionally, hyaluronic acid is an important cancer biomarker, particularly of breast and prostate cancer. It is important to note here that one in nine men are at a risk of developing prostate cancer. Moreover, it is particularly true of older men who are at a higher risk. On the other hand, around 2.1 million women are impacted by breast cancer annually. This is likely to fuel the growth of the global hyaluronic acid products market.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hyaluronic Acid Products Market

Single-injection Cycle V/S Five-injection Cycle: Which is Better?

Companies in the hyaluronic acid products market are boosting output capacities for single-injection, three-injection, and five-injection cycle products. Over the past few years, the revenue share of five-injection cycle is anticipated to lead among all product types. However, over the years, it has lost some share. The demand for hyaluronic acid molecule as the single-injection cycle treatment is preferred over five-injection cycles. This can be attributed to the growing demand for convenience among patients and the pressing need to avoid adverse effects that may arise after being exposed to the treatment. Shifting to a lower-duration treatment can help patients avoid symptoms such as itching, redness, and inflammation, which may be common after every dose. In the near future, the revenue share of single-injection cycle products will rise at a major CAGR over the forecast period.

Orthopedic and Ophthalmic Applications Catalyzing Demand for Hyaluronic Acid

Hyaluronic acid, one of the key components of the extracellular matrix (ECM), is a unique non-sulfated glycosaminoglycan that is well-distributed across different types of tissues such as connective tissues, epithelial, and neural tissues. The molecule performs a variety of physiological functions and has wide applications in areas of drug delivery, skin healing, and wound repair, particularly fetal wound healing. It is also shown to moderate the inflammation necessary for stabilizing the granulation tissue, thereby promoting healing.

The hyaluronic acid is being used as a biomarker for various cancer types, especially that of prostate and breast. In addition, they can help in monitoring the disease progression. Since the molecule promotes normal cushioning of tissues and lubricates the joints, it has wide applications in the orthopedic surgery. It also finds use in various eye surgeries, such as cataract removal and corneal transplantation.

Hyaluronic Acid Products Market: Overview

  • According to Transparency Market Research’s latest report on the global hyaluronic acid products market for the historical period 2017–2019 and forecast period 2021–2028, the market is anticipated to expand significantly owing to an aging population and the introduction of technologically advanced products

Buying Pattern of Hyaluronic Acid Beauty Products Characterized by Rise in Aging Population and Skin Problems (Pimples and Scars): Key Driver

  • People today not only prefer cosmetic products, but are also attracted to novel advancements in the beauty and cosmetics sector; for instance, better dermal fillers inside the skin, and the amount of penetration a particular product has with the skin, are leading to a shift in the demand pattern for hyaluronic acid beauty products globally
  • Demand for international cosmetic products is increasing, as they are more sensitive to the skin. Cost-effective treatments, rapid absorption of hyaluronic acid into the skin, anti aging hyaluronic acid beauty products, and hyaluronic acid injectable are further anticipated to propel the hyaluronic acid beauty products market

Wide Range of Beauty Products at Affordable Prices Driving Demand: Key Opportunity

  • Affluent shoppers buy beauty products around the world in stores such as Sephora, MAC, and Lakme, which has increased consumer footfalls in stores stocking beauty products with hyaluronic acid. Some of the products containing hyaluronic acid are Plum Youthful Radiance Duo, Skin Plumping Water Sleep Mask, Neutrogena, and Lancome Absolute, which are commonly available on the internet at a wide price range.
  • The popularity of hyaluronic acid has led it to be considered as one of the gold standard ingredients to hydrate the skin, which is a key factor driving the market. Beauty products account for a significantly high share of the market, because beauty routines have become the need of customers in their day-to-day lives. Changing lifestyle of people has also extensively influenced the sale of hyaluronic acid beauty products globally.

Hyaluronic Acid Products Market: Competition Landscape

  • This report profiles major players in the global hyaluronic acid products market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global hyaluronic acid products market is highly fragmented, with the presence of numerous international as well as regional players
  • Leading players operating in the global hyaluronic acid products market are
    • Alcon, Inc.
    • Anika Therapeutics, Inc.
    • Allergan, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Fidia Farmaceutici SpA
    • Ferring Pharmaceuticals, Inc.
    • GALDERMA S.A.
    • LifeCore Biomedical LLC
    • Hyaltech Ltd.
    • Meiji Seika Pharma Co., Ltd.
    • Sanofi
    • Merz Aesthetics, Inc.
    • Salix Pharmaceuticals, Inc.
    • Shanghai Jingfeng Pharmaceutical Co., Ltd.
    • Seikagaku Corp.
    • Smith & Nephew plc.
    • Zimmer Holdings, Inc.
    • TRB Chemedica Int. SA

Hyaluronic Acid Products Market: Key Developments

  • Key players in the global hyaluronic acid products market are expanding their presence in the market by adopting various strategies, such as mergers & acquisitions and research collaborations with other companies, to launch innovative products and consolidate their positions in the market across the world. A few expansion strategies adopted by players operating in the global hyaluronic acid products market are:
    • In June 2020, AbbVie announced the approval of a new hyaluronic acid product—Juvederm Voluma XC—indicated for improving chin profile in adults
    • In December 2019, Anika Therapeutics launched its first hyaluronic acid-based surgically delivered regenerative therapy, TACTOSET in the U.S., for the treatment of bone defects caused by trauma or degeneration
  • The report on the global hyaluronic acid products market discusses individual strategies, followed by company profiles of manufacturers of hyaluronic acid products market products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global hyaluronic acid products market.

Hyaluronic Acid Products Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 8.5 Bn

Market Forecast Value in 2028

US$ 15.2 Bn

Growth Rate (CAGR)

7.1%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market Player – Competition Matrix (By Tier and Size of  companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Product
    • Single-injection Cycle
    • Three-injection Cycle
    • Five-injection Cycle
  • By Application
    • Osteoarthritis
    • Ophthalmic Surgery
    • Dermal Fillers
    • Vesicoureteral Reflux (VUR)

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Alcon, Inc.
  • Anika Therapeutics, Inc.
  • Allergan, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fidia Farmaceutici SpA
  • Ferring Pharmaceuticals, Inc.
  • GALDERMA S.A.
  • LifeCore Biomedical LLC
  • Hyaltech Ltd.
  • Meiji Seika Pharma Co., Ltd.
  • Sanofi
  • Merz Aesthetics, Inc.
  • Salix Pharmaceuticals, Inc.
  • Shanghai Jingfeng Pharmaceutical Co., Ltd.
  • Seikagaku Corp.
  • Smith & Nephew plc.
  • Zimmer Holdings, Inc.
  • TRB Chemedica Int. SA
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Hyaluronic Acid Products Market – Segmentation

Product
  • Single-injection Cycle
  • Three-injection Cycle
  • Five-injection Cycle
Application
  • Osteoarthritis
  • Ophthalmic Surgery
  • Dermal Fillers
  • Vesicoureteral Reflux (VUR)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of hyaluronic acid products market?

Hyaluronic acid products market is expected to cross the value of US$ 15.2 Bn by the end of 2028

What is the anticipated CAGR of the hyaluronic acid products market in the forecast period?

Hyaluronic acid products market is estimated to expand at a CAGR of 7.1% from 2021 to 2028

What are the key driving factors for the growth of the hyaluronic acid products market?

Hyaluronic acid products market is driven by rise in cases of bone and joint-related issues

Which is the rising prominent segment in the hyaluronic acid products market?

The vesicoureteral reflux segment dominated the global hyaluronic acid products market and is projected to expand considerably during the forecast period

Who are the key players in the global hyaluronic acid products market?

Key players in the global hyaluronic acid products market include Alcon, Inc., Anika Therapeutics, Inc., Allergan, Inc., F. Hoffmann-La Roche Ltd., Fidia Farmaceutici SpA, Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Hyaluronic Acid Products Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Hyaluronic Acid Products Market Analysis and Forecast, 2018–2028

    5. Key Insights

        5.1. Key Mergers & Acquisitions

        5.2. Regulatory Scenario by Region/globally

        5.3. Product/ Brand Analysis

        5.4. Technological Advancements

        5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

    6. Global Hyaluronic Acid Products Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2018–2028

            6.3.1. Single-injection Cycle

            6.3.2. Three-injection Cycle

            6.3.3. Five-injection Cycle

        6.4. Market Attractiveness, by Product

    7. Global Hyaluronic Acid Products Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2018–2028

            7.3.1. Osteoarthritis

            7.3.2. Ophthalmic Surgery

            7.3.3. Dermal Fillers

            7.3.4. Vesicoureteral Reflux (VUR)

        7.4. Market Attractiveness, by Application

    8. Global Hyaluronic Acid Products Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness, by Country/Region

    9. North America Hyaluronic Acid Products Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product, 2018–2028

            9.2.1. Single-injection Cycle

            9.2.2. Three-injection Cycle

            9.2.3. Five-injection Cycle

        9.3. Market Value Forecast, by Application, 2018–2028

            9.3.1. Osteoarthritis

            9.3.2. Ophthalmic Surgery

            9.3.3. Dermal Fillers

            9.3.4. Vesicoureteral Reflux (VUR)

        9.4. Market Value Forecast, by Country, 2018–2028

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By Application

            9.5.3. By Country

    10. Europe Hyaluronic Acid Products Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2018–2028

            10.2.1. Single-injection Cycle

            10.2.2. Three-injection Cycle

            10.2.3. Five-injection Cycle

        10.3. Market Value Forecast, by Application, 2018–2028

            10.3.1. Osteoarthritis

            10.3.2. Ophthalmic Surgery

            10.3.3. Dermal Fillers

            10.3.4. Vesicoureteral Reflux (VUR)

        10.4. Market Value Forecast, by Country & Sub-region, 2018–2028

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By Application

            10.5.3. By Country & Sub-region

    11. Asia Pacific Hyaluronic Acid Products Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2018–2028

            11.2.1. Single-injection Cycle

            11.2.2. Three-injection Cycle

            11.2.3. Five-injection Cycle

        11.3. Market Value Forecast, by Application, 2018–2028

            11.3.1. Osteoarthritis

            11.3.2. Ophthalmic Surgery

            11.3.3. Dermal Fillers

            11.3.4. Vesicoureteral Reflux (VUR)

        11.4. Market Value Forecast, by Country & Sub-region, 2018–2028

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By Application

            11.5.3. By Country & Sub-region

    12. Latin America Hyaluronic Acid Products Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2018–2028

            12.2.1. Single-injection Cycle

            12.2.2. Three-injection Cycle

            12.2.3. Five-injection Cycle

        12.3. Market Value Forecast, by Application, 2018–2028

            12.3.1. Osteoarthritis

            12.3.2. Ophthalmic Surgery

            12.3.3. Dermal Fillers

            12.3.4. Vesicoureteral Reflux (VUR)

        12.4. Market Value Forecast, by Country & Sub-region, 2018–2028

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By Application

            12.5.3. By Country & Sub-region

    13. Middle East & Africa Hyaluronic Acid Products Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2018–2028

            13.2.1. Single-injection Cycle

            13.2.2. Three-injection Cycle

            13.2.3. Five-injection Cycle

        13.3. Market Value Forecast, by Application, 2018–2028

            13.3.1. Osteoarthritis

            13.3.2. Ophthalmic Surgery

            13.3.3. Dermal Fillers

            13.3.4. Vesicoureteral Reflux (VUR)

        13.4. Market Value Forecast, by Country & Sub-region, 2018–2028

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By Application

            13.5.3. By Country & Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of companies)

        14.2. Market Share Analysis By Company (2020)

        14.3. Company Profiles

            14.3.1. Alcon, Inc.

                14.3.1.1. Company Details

                14.3.1.2. Business Overview

                14.3.1.3. Financial Overview

                14.3.1.4. Strategic Overview

                14.3.1.5. SWOT Analysis

            14.3.2. Anika Therapeutics, Inc.

                14.3.2.1. Company Details

                14.3.2.2. Business Overview

                14.3.2.3. Financial Overview

                14.3.2.4. Strategic Overview

                14.3.2.5. SWOT Analysis

            14.3.3. Allergan, Inc.

                14.3.3.1. Company Details

                14.3.3.2. Business Overview

                14.3.3.3. Financial Overview

                14.3.3.4. Strategic Overview

                14.3.3.5. SWOT Analysis

            14.3.4. F. Hoffmann-La Roche Ltd.

                14.3.4.1. Company Details

                14.3.4.2. Business Overview

                14.3.4.3. Financial Overview

                14.3.4.4. Strategic Overview

                14.3.4.5. SWOT Analysis

            14.3.5. Fidia Farmaceutici SpA

                14.3.5.1. Company Details

                14.3.5.2. Business Overview

                14.3.5.3. Financial Overview

                14.3.5.4. Strategic Overview

                14.3.5.5. SWOT Analysis

            14.3.6. Ferring Pharmaceuticals, Inc.

                14.3.6.1. Company Details

                14.3.6.2. Business Overview

                14.3.6.3. Financial Overview

                14.3.6.4. Strategic Overview

                14.3.6.5. SWOT Analysis

            14.3.7. GALDERMA S.A.

                14.3.7.1. Company Details

                14.3.7.2. Business Overview

                14.3.7.3. Financial Overview

                14.3.7.4. Strategic Overview

                14.3.7.5. SWOT Analysis

            14.3.8. LifeCore Biomedical LLC

                14.3.8.1. Company Details

                14.3.8.2. Business Overview

                14.3.8.3. Financial Overview

                14.3.8.4. Strategic Overview

                14.3.8.5. SWOT Analysis

            14.3.9. Hyaltech Ltd.

                14.3.9.1. Company Details

                14.3.9.2. Business Overview

                14.3.9.3. Financial Overview

                14.3.9.4. Strategic Overview

                14.3.9.5. SWOT Analysis

            14.3.10. Meiji Seika Pharma Co., Ltd.

                14.3.10.1. Company Details

                14.3.10.2. Business Overview

                14.3.10.3. Financial Overview

                14.3.10.4. Strategic Overview

                14.3.10.5. SWOT Analysis

            14.3.11. Sanofi

                14.3.11.1. Company Details

                14.3.11.2. Business Overview

                14.3.11.3. Financial Overview

                14.3.11.4. Strategic Overview

                14.3.11.5. SWOT Analysis

            14.3.12. Merz Aesthetics, Inc.

                14.3.12.1. Company Details

                14.3.12.2. Business Overview

                14.3.12.3. Financial Overview

                14.3.12.4. Strategic Overview

                14.3.12.5. SWOT Analysis

            14.3.13. Salix Pharmaceuticals, Inc.

                14.3.13.1. Company Details

                14.3.13.2. Business Overview

                14.3.13.3. Financial Overview

                14.3.13.4. Strategic Overview

                14.3.13.5. SWOT Analysis

            14.3.14. Shanghai Jingfeng Pharmaceutical Co., Ltd.

                14.3.14.1. Company Details

                14.3.14.2. Business Overview

                14.3.14.3. Financial Overview

                14.3.14.4. Strategic Overview

                14.3.14.5. SWOT Analysis

            14.3.15. Seikagaku Corp.

                14.3.15.1. Company Details

                14.3.15.2. Business Overview

                14.3.15.3. Financial Overview

                14.3.15.4. Strategic Overview

                14.3.15.5. SWOT Analysis

            14.3.16. Smith & Nephew plc.

                14.3.16.1. Company Details

                14.3.16.2. Business Overview

                14.3.16.3. Financial Overview

                14.3.16.4. Strategic Overview

                14.3.16.5. SWOT Analysis

            14.3.17. Zimmer Holdings, Inc.

                14.3.17.1. Company Details

                14.3.17.2. Business Overview

                14.3.17.3. Financial Overview

                14.3.17.4. Strategic Overview

                14.3.17.5. SWOT Analysis

            14.3.18. TRB Chemedica Int. SA

                14.3.18.1. Company Details

                14.3.18.2. Business Overview

                14.3.18.3. Financial Overview

                14.3.18.4. Strategic Overview

                14.3.18.5. SWOT Analysis

            14.3.19. Other Prominent Players

                14.3.19.1. Company Details

                14.3.19.2. Business Overview

                14.3.19.3. Financial Overview

                14.3.19.4. Strategic Overview

                14.3.19.5. SWOT Analysis

    List of Tables

    Table 1: Market Snapshot: Global Hyaluronic Acid Products Market (2020 & 2028)

    Table 2: Global Hyaluronic Acid Products Market Revenue, by Products, 2017 –2028 (USD Million)

    Table 3: Global Hyaluronic Acid Products Market Revenue, by Applications, 2017 –2028 (USD Million)

    Table 4: Global Hyaluronic Acid Products Market Revenue, by Geography, 2017 –2028 (USD Million)

    List of Figures

    Figure 1: Hyaluronic Acid Products: Market Segmentation

    Figure 2: Global Hyaluronic Acid Products Market, by Products, 2018 (USD Million)

    Figure 3: Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2020 and 2028 (Value %)

    Figure 4: Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market

    Figure 5: Production Methods of Hyaluronic acid

    Figure 6: Market Attractiveness Analysis: Global Hyaluronic Acid Products Market

    Figure 7: Market Share Analysis: Hyaluronic Acid Products Market, 2020 (Value %)

    Figure 8: Comparative Analysis: Types of Hyaluronic Acid Products

    Figure 9: Global Single-Injection Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 10: Global Three-Injection Cycle Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 11: Global Five-Injection Cycle Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 12: Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2018 – 2020 (USD Million)

    Figure 13: Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2018 – 2020 (USD Million)

    Figure 14: Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2018 – 2020 (USD Million)

    Figure 15: Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2018 – 2020 (USD Million)

    Figure 16: North America Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 17: Europe Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 18: Asia-Pacific Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 19: Latin America Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 20: Middle East & Africa Hyaluronic Acid Products Market Revenue, 2018 – 2020 (USD Million)

    Figure 21: Alcon, Inc., Annual Revenue: 2010 – 2018 (USD Million)

    Figure 22: Allergan, Inc., Annual Sales Revenue: 2010 – 2018 (USD Million)

    Figure 23: Anika Therapeutics, Inc., Annual Revenue: 2010– 2018 (USD Million)

    Figure 24: F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2018 (USD Million)

    Figure 25: Galderma S.A., Annual Revenue: 2010 – 2018 (USD Million)

    Figure 26: Lifecore Biomedical LLC. Annual Revenue: 2010– 2018 (USD Million)

    Figure 27: Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 – 2018 (USD Million)

    Figure 28: Merz Aesthetics Inc., Annual revenue: 2010 – 2018 (USD Million)

    Figure 29: Sanofi, Annual Revenue: 2010 – 2018 (USD Million)

    Figure 30: Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2018 (USD Million)

    Figure 31: Seikagaku Corporation, Annual Revenue: 2010 – 2018 (USD Million)

    Figure 32: Smith & Nephew PLC, Annual Revenue: 2010 – 2018 (USD Million)

    Figure 33: Zimmer Holdings. Inc., Annual Revenue: 2010 – 2018 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved